Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now.

Duane Boise CEO MMJ International Holdings stated "You cannot shortcut the FDA. Many companies are just now deciding they want to be pharmaceutical, but the real barrier to entry is time spent inside ...

Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.

Fully automated “self-driving” process development labs are an attractive idea, but human expertise and oversight will always be needed.

This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.

Here’s how drug developers can best approach interactions with the agency following last year’s seismic changes to its leadership, workforce and policies.

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

TD Cowen 46th Annual Health Care Conference March 2, 2026 10:30 AM ESTCompany ParticipantsSujal Patel - Co-Founder, ...

The latest milestone follows PathAI’s 510(k) clearance for AISight Dx, the first FDA-approved digital pathology system.

Get the latest Sai Life Sciences share price today on NSE & BSE. Explore Sai Life Sciences stock analysis, financial performance, market capitalization, dividend history, and future outlook for ...

The FDA has outlined a proposed approval pathway for customized drugs and gene-editing therapies designed for rare and ...

Incentives to bring vaccines to market are shrinking. Drugmakers are scaling back research investments and cutting jobs.